Obsidian FlamesObsidian Flames🃏All Pawmot cards
Ask about Pawmot ex
Pawmot ex #73 Pokémon card from Obsidian Flames

Pawmot ex 73/197

Obsidian Flames

Find this card on eBay

Affiliate link · we may earn commission

Pawmot ex #73 from Obsidian Flames currently trades at $1.19 raw, with PSA 10 copies reaching $43.70 — a 36.7x grade premium.
Current Prices (USD)
Ungraded
$1.19
PSA 7
$4.76
PSA 8
$6.00
PSA 9
$8.06
PSA 10
$43.70
ACE 10
BGS 10 Black
$285.00
CGC 10 Pristine
$19.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Pawmot ex 73/197 from Obsidian Flames has a current raw market value of $1.19.

Current raw value
$1.19
PSA 9 value
$8.06
PSA 10 value
$43.70
PSA 10 premium vs raw
36.7× raw
View all cards from Obsidian Flames
Collector Intel
36.7x
Raw → PSA 10
High-risk grade
6.8x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 37x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$44
PSA 10 Value
+$18
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$86.8x raw
PSA 10$4436.7x raw

Frequently asked questions

How much is Pawmot ex #73 from Obsidian Flames worth?+
Pawmot ex #73 from Obsidian Flames is currently worth Raw: $1.19, PSA 9: $8.06, PSA 10: $43.70 based on recent sold listings. Prices update daily from real eBay sales.
Is Pawmot ex #73 worth grading?+
The PSA 10 price of $43.70 is 36.7× the raw price of $1.19. After a ~$25 grading fee, a PSA 10 result would net approximately $42.51 — assuming the card grades a 10.
Where do PokePrices Pawmot ex #73 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.